Pharma IQ | 11/08/2010
In this interview Jerold Martin, Sr. V.P., Global Scientific Affairs, Biopharmaceuticals, Pall Life Sciences and Chairman of the Board and Technology Committee at the BPSA, speaks to Andrea Charles from Pharma IQ, about future trends for Single-Use biomanufacturing and the advantages of Single-Use systems for biomanufacturing. Martin also shares his experiences regarding what factors to consider when implementing a Single-Use technology and their environmental impact.
To continue reading this story Click Here
RECOMMENDED
Pharma Contract Manufacturing 2025
2025-03-03
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Upcoming Events
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More